UPLY MEDIA, INC. // HEALTHCARE SYSTEMS GOVERNANCE DIVISION

TOXI-CHARTER™

Institutional PACT Act Clinical Documentation & Evidentiary Defensibility Standard

System Standard Designation: Institutional Operating Standard UMS-STD-2026-TOXICHARTER

Proprietary Mark Status: Proprietary Commercial Trademark of Uply Media, Inc.

Primary Federal Classifications:

IC 035: Medical center management consulting; public health regulatory compliance auditing; administrative oversight of military environmental exposure screening records.
IC 042: Healthcare compliance testing and quality verification; institutional evidentiary screening audits for electronic health records under federal statutory mandates.

MANDATORY NOTICE OF FIRST USE IN COMMERCE & SENIOR COMMON LAW PRIORITY

LEGAL NOTICE TO ALL THIRD PARTIES AND PROSPECTIVE REGISTRANTS:

Pursuant to the Trademark Act of 1946 (The Lanham Act), 15 U.S.C. § 1051 et seq. and 15 U.S.C. § 1127, the commercial mark TOXI-CHARTER™ was formally placed into active interstate commerce by Uply Media, Inc. on this verified domain. Uply Media, Inc. asserts unbroken, senior common-law priority across all federal, regional, and commercial healthcare jurisdictions.

STATUTORY DETERRENCE WARNING: Any third party attempting to register, file an Intent-to-Use (ITU) application under 15 U.S.C. § 1051(b), or commercially deploy an identical or confusingly similar mark is on formal constructive and actual notice of senior use. Submitting a verified application to the U.S. Patent and Trademark Office falsely claiming bona fide intent without knowledge of prior rights constitutes a false declaration under 18 U.S.C. § 1001 and fraud on the USPTO. Any bad-faith filing or confusingly similar commercial adoption will be met with immediate opposition, cancellation proceedings before the Trademark Trial and Appeal Board (TTAB), and federal civil litigation for willful trademark infringement, unfair competition, and false designation of origin under 15 U.S.C. § 1125(a), subjecting the infringing party to treble damages, disgorgement of profits, and mandatory attorney fees under 15 U.S.C. § 1117.

EVIDENTIARY ARCHIVE STAMP: This webpage is cryptographically timestamped, logged via immutable host server records, and preserved through independent third-party digital preservation repositories under Federal Rules of Evidence Rule 902(13) and Rule 902(14) (Self-Authenticating Electronic Records).

Commercial Framework Scope

The TOXI-CHARTER™ operating standard equips Veterans Health Administration medical centers and regional networks with standardized clinical charting and evidentiary verification protocols for military toxic exposures under Public Law 117-168 (The PACT Act). The framework establishes defensible environmental screening pathways, presumptive exposure correlation standards, and documentation controls that prevent VA Office of Inspector General (OIG) audit citations and disability claim remands.

Institutional Deliverables & Governance Architecture

Presumptive Exposure Linkage Protocol: Standardized clinical charting criteria governing military deployment theater verification, toxic hazard specificity, latency interval concordance, and functional impairment.
Environmental Screening Defensibility Protocol: Systematic quality-assurance controls preventing incomplete primary care screenings from entering the permanent medical record.
EHR-to-Evidentiary Alignment Standards: Structured clinical charting parameters ensuring healthcare encounter notes withstand administrative review without requiring duplicative examinations.

Commercial Licensing & Acquisition Tiers

VISN Enterprise Site License (UMS-LIC-ENT):

$1,500,000.00 USD (Firm-Fixed-Price)

Regional network authorization covering all medical centers and CBOCs within a designated VISN. Funded directly via the Toxic Exposures Fund (TEF) under FAR 12.211 and FAR 12.212 Restricted Commercial Technical Data Rights.

Facility Programmatic Implementation License (UMS-LIC-FAC):

$350,000.00 USD (Annual Firm-Fixed-Price)

Single VA Medical Center operational authorization, clinical decision-tree deployment, and baseline PACT Act compliance charting audit.

Enterprise Sole-Source Turnkey Program (Full 4-CLIN Architecture):

$5,000,000.00 USD

Non-competitive prime contract under 38 U.S.C. § 8127(c) and VAAR 819.7008, combining network-wide site licensing, physical documentation, empirical audits, and 24-month defensibility retaining.

Preliminary Departmental Evaluation & Briefing Voucher:

$14,950.00 USD (Firm-Fixed-Price)

Authorized for rapid acquisition via Government Purchase Card (GPC) micro-purchase. Covers initial facility screening audit scoping, executive leadership briefing, and PACT Act workflow evaluation.

REQUEST TEF SOLE-SOURCE PROPOSAL ($1.5M – $5M) ORDER PRELIMINARY GPC EVALUATION ($14,950)

Direct Acquisition Orders & Telephone Transactions: (470) 231-7367 | govservices@uplymedia.com

Prime Contractor: Uply Media, Inc. (SBA-Certified SDVOSB // UEI: YPE4G8X18N67 // CAGE: 9WMV4)

Freedom of Information Act (FOIA) Exemption 4 Notice:

All underlying operating standards, software source code, audit algorithms, attestation matrices, and technical ledgers associated with HUMAN-CHARTER™, CLINI-CHARTER AI™, TOXI-CHARTER™, FORCE-SHIELD™, CLINI-SHIELD™, and PACT-SHIELD™ are confidential commercial technical data and trade secrets owned exclusively by Uply Media, Inc. Pursuant to 5 U.S.C. § 552(b)(4) and FAR 12.211/FAR 12.212, this technical data is strictly exempt from public disclosure and cannot be transferred, distributed, or solicited without prior written authorization from Uply Media, Inc.

© 2014–2026 Uply Media, Inc. All Rights Reserved.